Global Targeted Radiotherapy Drug Market Growth (Status and Outlook) 2026-2032

September 2026 | 92 pages | ID: G982F055AB5FEN
LP Information

Abstracts

The global Targeted Radiotherapy Drug market size is predicted to grow from US$ 6760 million in 2025 to US$ 10100 million in 2032; it is expected to grow at a CAGR of 6.0% from 2026 to 2032.

Targeted radiotherapy is a medical treatment designed to direct radioactive isotopes to specific types of tumor cells or tumor markers, allowing for precise tumor treatment. These drugs offer a promising treatment for some malignant tumors, especially those that are advanced or difficult to surgically remove. As technology develops, treatment effects, as well as patient survival and quality of life after treatment, can be better monitored and evaluated. The development trend of targeted radiotherapy drugs emphasizes precise treatment, personalized treatment and comprehensive treatment methods. This will hopefully provide more effective cancer treatments in the future and improve patient survival and quality of life.

LPI (LP Information)' newest research report, the “Targeted Radiotherapy Drug Industry Forecast” looks at past sales and reviews total world Targeted Radiotherapy Drug sales in 2025, providing a comprehensive analysis by region and market sector of projected Targeted Radiotherapy Drug sales for 2026 through 2032. With Targeted Radiotherapy Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Targeted Radiotherapy Drug industry.

This Insight Report provides a comprehensive analysis of the global Targeted Radiotherapy Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Targeted Radiotherapy Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Targeted Radiotherapy Drug market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Targeted Radiotherapy Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Targeted Radiotherapy Drug.

This report presents a comprehensive overview, market shares, and growth opportunities of Targeted Radiotherapy Drug market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Radioactive Iodine Therapeutic Drugs
• Radioactive Antibody Therapeutic Drugs
• Others

Segmentation by Application:

• General Hospital
• Specialty Hospital

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Novartis
• Bayer
• Endocyte
• Progenics Pharmaceuticals
• Jubilant Radiopharma
• Curium
• Fermi Energia
• Nucleus RadioPharma

Contents

1 SCOPE OF THE REPORT

  1.1 Market Introduction
  1.2 Years Considered
  1.3 Research Objectives
  1.4 Market Research Methodology
  1.5 Research Process and Data Source
  1.6 Economic Indicators
  1.7 Currency Considered
  1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

  2.1 World Market Overview
  2.1.1 Global Targeted Radiotherapy Drug Market Size (2021-2032)
  2.1.2 Targeted Radiotherapy Drug Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for Targeted Radiotherapy Drug by Country/Region (2021, 2025 & 2032)
  2.2 Targeted Radiotherapy Drug Segment by Type
  2.2.1 Radioactive Iodine Therapeutic Drugs
  2.2.2 Radioactive Antibody Therapeutic Drugs
  2.2.3 Others
  2.2.4 Targeted Radiotherapy Drug Market Size by Type
  2.2.4.1 Targeted Radiotherapy Drug Market Size CAGR by Type (2021 VS 2025 VS 2032)
  2.2.4.2 Global Targeted Radiotherapy Drug Market Size Market Share by Type (2021-2026)
  2.3 Targeted Radiotherapy Drug Segment by Application
  2.3.1 General Hospital
  2.3.2 Specialty Hospital
  2.3.3 Targeted Radiotherapy Drug Market Size by Application
  2.3.3.1 Targeted Radiotherapy Drug Market Size CAGR by Application (2021 VS 2025 VS 2032)
  2.3.3.2 Global Targeted Radiotherapy Drug Market Size Market Share by Application (2021-2026)

3 TARGETED RADIOTHERAPY DRUG MARKET SIZE BY PLAYER

  3.1 Targeted Radiotherapy Drug Market Size Market Share by Player
  3.1.1 Global Targeted Radiotherapy Drug Revenue by Player (2021-2026)
  3.1.2 Global Targeted Radiotherapy Drug Revenue Market Share by Player (2021-2026)
  3.2 Global Targeted Radiotherapy Drug Key Players Head office and Products Offered
  3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
  3.4 New Products and Potential Entrants
  3.5 Mergers & Acquisitions, Expansion

4 TARGETED RADIOTHERAPY DRUG BY REGION

  4.1 Targeted Radiotherapy Drug Market Size by Region (2021-2026)
  4.2 Global Targeted Radiotherapy Drug Annual Revenue by Country/Region (2021-2026)
  4.3 Americas Targeted Radiotherapy Drug Market Size Growth (2021-2026)
  4.4 APAC Targeted Radiotherapy Drug Market Size Growth (2021-2026)
  4.5 Europe Targeted Radiotherapy Drug Market Size Growth (2021-2026)
  4.6 Middle East & Africa Targeted Radiotherapy Drug Market Size Growth (2021-2026)

5 AMERICAS

  5.1 Americas Targeted Radiotherapy Drug Market Size by Country (2021-2026)
  5.2 Americas Targeted Radiotherapy Drug Market Size by Type (2021-2026)
  5.3 Americas Targeted Radiotherapy Drug Market Size by Application (2021-2026)
  5.4 United States
  5.5 Canada
  5.6 Mexico
  5.7 Brazil

6 APAC

  6.1 APAC Targeted Radiotherapy Drug Market Size by Region (2021-2026)
  6.2 APAC Targeted Radiotherapy Drug Market Size by Type (2021-2026)
  6.3 APAC Targeted Radiotherapy Drug Market Size by Application (2021-2026)
  6.4 China
  6.5 Japan
  6.6 South Korea
  6.7 Southeast Asia
  6.8 India
  6.9 Australia

7 EUROPE

  7.1 Europe Targeted Radiotherapy Drug Market Size by Country (2021-2026)
  7.2 Europe Targeted Radiotherapy Drug Market Size by Type (2021-2026)
  7.3 Europe Targeted Radiotherapy Drug Market Size by Application (2021-2026)
  7.4 Germany
  7.5 France
  7.6 UK
  7.7 Italy
  7.8 Russia

8 MIDDLE EAST & AFRICA

  8.1 Middle East & Africa Targeted Radiotherapy Drug by Region (2021-2026)
  8.2 Middle East & Africa Targeted Radiotherapy Drug Market Size by Type (2021-2026)
  8.3 Middle East & Africa Targeted Radiotherapy Drug Market Size by Application (2021-2026)
  8.4 Egypt
  8.5 South Africa
  8.6 Israel
  8.7 Turkey
  8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

  9.1 Market Drivers & Growth Opportunities
  9.2 Market Challenges & Risks
  9.3 Industry Trends

10 GLOBAL TARGETED RADIOTHERAPY DRUG MARKET FORECAST

  10.1 Global Targeted Radiotherapy Drug Forecast by Region (2027-2032)
  10.1.1 Global Targeted Radiotherapy Drug Forecast by Region (2027-2032)
  10.1.2 Americas Targeted Radiotherapy Drug Forecast
  10.1.3 APAC Targeted Radiotherapy Drug Forecast
  10.1.4 Europe Targeted Radiotherapy Drug Forecast
  10.1.5 Middle East & Africa Targeted Radiotherapy Drug Forecast
  10.2 Americas Targeted Radiotherapy Drug Forecast by Country (2027-2032)
  10.2.1 United States Market Targeted Radiotherapy Drug Forecast
  10.2.2 Canada Market Targeted Radiotherapy Drug Forecast
  10.2.3 Mexico Market Targeted Radiotherapy Drug Forecast
  10.2.4 Brazil Market Targeted Radiotherapy Drug Forecast
  10.3 APAC Targeted Radiotherapy Drug Forecast by Region (2027-2032)
  10.3.1 China Targeted Radiotherapy Drug Market Forecast
  10.3.2 Japan Market Targeted Radiotherapy Drug Forecast
  10.3.3 Korea Market Targeted Radiotherapy Drug Forecast
  10.3.4 Southeast Asia Market Targeted Radiotherapy Drug Forecast
  10.3.5 India Market Targeted Radiotherapy Drug Forecast
  10.3.6 Australia Market Targeted Radiotherapy Drug Forecast
  10.4 Europe Targeted Radiotherapy Drug Forecast by Country (2027-2032)
  10.4.1 Germany Market Targeted Radiotherapy Drug Forecast
  10.4.2 France Market Targeted Radiotherapy Drug Forecast
  10.4.3 UK Market Targeted Radiotherapy Drug Forecast
  10.4.4 Italy Market Targeted Radiotherapy Drug Forecast
  10.4.5 Russia Market Targeted Radiotherapy Drug Forecast
  10.5 Middle East & Africa Targeted Radiotherapy Drug Forecast by Region (2027-2032)
  10.5.1 Egypt Market Targeted Radiotherapy Drug Forecast
  10.5.2 South Africa Market Targeted Radiotherapy Drug Forecast
  10.5.3 Israel Market Targeted Radiotherapy Drug Forecast
  10.5.4 Turkey Market Targeted Radiotherapy Drug Forecast
  10.6 Global Targeted Radiotherapy Drug Forecast by Type (2027-2032)
  10.7 Global Targeted Radiotherapy Drug Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market Targeted Radiotherapy Drug Forecast

11 KEY PLAYERS ANALYSIS

  11.1 Novartis
  11.1.1 Novartis Company Information
  11.1.2 Novartis Targeted Radiotherapy Drug Product Offered
  11.1.3 Novartis Targeted Radiotherapy Drug Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 Novartis Main Business Overview
  11.1.5 Novartis Latest Developments
  11.2 Bayer
  11.2.1 Bayer Company Information
  11.2.2 Bayer Targeted Radiotherapy Drug Product Offered
  11.2.3 Bayer Targeted Radiotherapy Drug Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 Bayer Main Business Overview
  11.2.5 Bayer Latest Developments
  11.3 Endocyte
  11.3.1 Endocyte Company Information
  11.3.2 Endocyte Targeted Radiotherapy Drug Product Offered
  11.3.3 Endocyte Targeted Radiotherapy Drug Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 Endocyte Main Business Overview
  11.3.5 Endocyte Latest Developments
  11.4 Progenics Pharmaceuticals
  11.4.1 Progenics Pharmaceuticals Company Information
  11.4.2 Progenics Pharmaceuticals Targeted Radiotherapy Drug Product Offered
  11.4.3 Progenics Pharmaceuticals Targeted Radiotherapy Drug Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 Progenics Pharmaceuticals Main Business Overview
  11.4.5 Progenics Pharmaceuticals Latest Developments
  11.5 Jubilant Radiopharma
  11.5.1 Jubilant Radiopharma Company Information
  11.5.2 Jubilant Radiopharma Targeted Radiotherapy Drug Product Offered
  11.5.3 Jubilant Radiopharma Targeted Radiotherapy Drug Revenue, Gross Margin and Market Share (2021-2026)
  11.5.4 Jubilant Radiopharma Main Business Overview
  11.5.5 Jubilant Radiopharma Latest Developments
  11.6 Curium
  11.6.1 Curium Company Information
  11.6.2 Curium Targeted Radiotherapy Drug Product Offered
  11.6.3 Curium Targeted Radiotherapy Drug Revenue, Gross Margin and Market Share (2021-2026)
  11.6.4 Curium Main Business Overview
  11.6.5 Curium Latest Developments
  11.7 Fermi Energia
  11.7.1 Fermi Energia Company Information
  11.7.2 Fermi Energia Targeted Radiotherapy Drug Product Offered
  11.7.3 Fermi Energia Targeted Radiotherapy Drug Revenue, Gross Margin and Market Share (2021-2026)
  11.7.4 Fermi Energia Main Business Overview
  11.7.5 Fermi Energia Latest Developments
  11.8 Nucleus RadioPharma
  11.8.1 Nucleus RadioPharma Company Information
  11.8.2 Nucleus RadioPharma Targeted Radiotherapy Drug Product Offered
  11.8.3 Nucleus RadioPharma Targeted Radiotherapy Drug Revenue, Gross Margin and Market Share (2021-2026)
  11.8.4 Nucleus RadioPharma Main Business Overview
  11.8.5 Nucleus RadioPharma Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Targeted Radiotherapy Drug Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Targeted Radiotherapy Drug Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Radioactive Iodine Therapeutic Drugs
Table 4. Major Players of Radioactive Antibody Therapeutic Drugs
Table 5. Major Players of Others
Table 6. Targeted Radiotherapy Drug Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Targeted Radiotherapy Drug Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Targeted Radiotherapy Drug Market Size Market Share by Type (2021-2026)
Table 9. Targeted Radiotherapy Drug Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Targeted Radiotherapy Drug Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Targeted Radiotherapy Drug Market Size Market Share by Application (2021-2026)
Table 12. Global Targeted Radiotherapy Drug Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Targeted Radiotherapy Drug Revenue Market Share by Player (2021-2026)
Table 14. Targeted Radiotherapy Drug Key Players Head office and Products Offered
Table 15. Targeted Radiotherapy Drug Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Targeted Radiotherapy Drug Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Targeted Radiotherapy Drug Market Size Market Share by Region (2021-2026)
Table 20. Global Targeted Radiotherapy Drug Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Targeted Radiotherapy Drug Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Targeted Radiotherapy Drug Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Targeted Radiotherapy Drug Market Size Market Share by Country (2021-2026)
Table 24. Americas Targeted Radiotherapy Drug Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Targeted Radiotherapy Drug Market Size Market Share by Type (2021-2026)
Table 26. Americas Targeted Radiotherapy Drug Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Targeted Radiotherapy Drug Market Size Market Share by Application (2021-2026)
Table 28. APAC Targeted Radiotherapy Drug Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Targeted Radiotherapy Drug Market Size Market Share by Region (2021-2026)
Table 30. APAC Targeted Radiotherapy Drug Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Targeted Radiotherapy Drug Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Targeted Radiotherapy Drug Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Targeted Radiotherapy Drug Market Size Market Share by Country (2021-2026)
Table 34. Europe Targeted Radiotherapy Drug Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Targeted Radiotherapy Drug Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Targeted Radiotherapy Drug Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Targeted Radiotherapy Drug Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Targeted Radiotherapy Drug Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Targeted Radiotherapy Drug
Table 40. Key Market Challenges & Risks of Targeted Radiotherapy Drug
Table 41. Key Industry Trends of Targeted Radiotherapy Drug
Table 42. Global Targeted Radiotherapy Drug Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Targeted Radiotherapy Drug Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Targeted Radiotherapy Drug Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Targeted Radiotherapy Drug Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. Novartis Details, Company Type, Targeted Radiotherapy Drug Area Served and Its Competitors
Table 47. Novartis Targeted Radiotherapy Drug Product Offered
Table 48. Novartis Targeted Radiotherapy Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. Novartis Main Business
Table 50. Novartis Latest Developments
Table 51. Bayer Details, Company Type, Targeted Radiotherapy Drug Area Served and Its Competitors
Table 52. Bayer Targeted Radiotherapy Drug Product Offered
Table 53. Bayer Targeted Radiotherapy Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Bayer Main Business
Table 55. Bayer Latest Developments
Table 56. Endocyte Details, Company Type, Targeted Radiotherapy Drug Area Served and Its Competitors
Table 57. Endocyte Targeted Radiotherapy Drug Product Offered
Table 58. Endocyte Targeted Radiotherapy Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Endocyte Main Business
Table 60. Endocyte Latest Developments
Table 61. Progenics Pharmaceuticals Details, Company Type, Targeted Radiotherapy Drug Area Served and Its Competitors
Table 62. Progenics Pharmaceuticals Targeted Radiotherapy Drug Product Offered
Table 63. Progenics Pharmaceuticals Targeted Radiotherapy Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Progenics Pharmaceuticals Main Business
Table 65. Progenics Pharmaceuticals Latest Developments
Table 66. Jubilant Radiopharma Details, Company Type, Targeted Radiotherapy Drug Area Served and Its Competitors
Table 67. Jubilant Radiopharma Targeted Radiotherapy Drug Product Offered
Table 68. Jubilant Radiopharma Targeted Radiotherapy Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Jubilant Radiopharma Main Business
Table 70. Jubilant Radiopharma Latest Developments
Table 71. Curium Details, Company Type, Targeted Radiotherapy Drug Area Served and Its Competitors
Table 72. Curium Targeted Radiotherapy Drug Product Offered
Table 73. Curium Targeted Radiotherapy Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Curium Main Business
Table 75. Curium Latest Developments
Table 76. Fermi Energia Details, Company Type, Targeted Radiotherapy Drug Area Served and Its Competitors
Table 77. Fermi Energia Targeted Radiotherapy Drug Product Offered
Table 78. Fermi Energia Targeted Radiotherapy Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Fermi Energia Main Business
Table 80. Fermi Energia Latest Developments
Table 81. Nucleus RadioPharma Details, Company Type, Targeted Radiotherapy Drug Area Served and Its Competitors
Table 82. Nucleus RadioPharma Targeted Radiotherapy Drug Product Offered
Table 83. Nucleus RadioPharma Targeted Radiotherapy Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Nucleus RadioPharma Main Business
Table 85. Nucleus RadioPharma Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Targeted Radiotherapy Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Targeted Radiotherapy Drug Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Targeted Radiotherapy Drug Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Targeted Radiotherapy Drug Sales Market Share by Country/Region (2025)
Figure 8. Targeted Radiotherapy Drug Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Targeted Radiotherapy Drug Market Size Market Share by Type in 2025
Figure 10. Targeted Radiotherapy Drug in General Hospital
Figure 11. Global Targeted Radiotherapy Drug Market: General Hospital (2021-2026) & ($ millions)
Figure 12. Targeted Radiotherapy Drug in Specialty Hospital
Figure 13. Global Targeted Radiotherapy Drug Market: Specialty Hospital (2021-2026) & ($ millions)
Figure 14. Global Targeted Radiotherapy Drug Market Size Market Share by Application in 2025
Figure 15. Global Targeted Radiotherapy Drug Revenue Market Share by Player in 2025
Figure 16. Global Targeted Radiotherapy Drug Market Size Market Share by Region (2021-2026)
Figure 17. Americas Targeted Radiotherapy Drug Market Size 2021-2026 ($ millions)
Figure 18. APAC Targeted Radiotherapy Drug Market Size 2021-2026 ($ millions)
Figure 19. Europe Targeted Radiotherapy Drug Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa Targeted Radiotherapy Drug Market Size 2021-2026 ($ millions)
Figure 21. Americas Targeted Radiotherapy Drug Value Market Share by Country in 2025
Figure 22. United States Targeted Radiotherapy Drug Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada Targeted Radiotherapy Drug Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico Targeted Radiotherapy Drug Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil Targeted Radiotherapy Drug Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC Targeted Radiotherapy Drug Market Size Market Share by Region in 2025
Figure 27. APAC Targeted Radiotherapy Drug Market Size Market Share by Type (2021-2026)
Figure 28. APAC Targeted Radiotherapy Drug Market Size Market Share by Application (2021-2026)
Figure 29. China Targeted Radiotherapy Drug Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan Targeted Radiotherapy Drug Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea Targeted Radiotherapy Drug Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia Targeted Radiotherapy Drug Market Size Growth 2021-2026 ($ millions)
Figure 33. India Targeted Radiotherapy Drug Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia Targeted Radiotherapy Drug Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe Targeted Radiotherapy Drug Market Size Market Share by Country in 2025
Figure 36. Europe Targeted Radiotherapy Drug Market Size Market Share by Type (2021-2026)
Figure 37. Europe Targeted Radiotherapy Drug Market Size Market Share by Application (2021-2026)
Figure 38. Germany Targeted Radiotherapy Drug Market Size Growth 2021-2026 ($ millions)
Figure 39. France Targeted Radiotherapy Drug Market Size Growth 2021-2026 ($ millions)
Figure 40. UK Targeted Radiotherapy Drug Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy Targeted Radiotherapy Drug Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia Targeted Radiotherapy Drug Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa Targeted Radiotherapy Drug Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa Targeted Radiotherapy Drug Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa Targeted Radiotherapy Drug Market Size Market Share by Application (2021-2026)
Figure 46. Egypt Targeted Radiotherapy Drug Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa Targeted Radiotherapy Drug Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel Targeted Radiotherapy Drug Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey Targeted Radiotherapy Drug Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries Targeted Radiotherapy Drug Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas Targeted Radiotherapy Drug Market Size 2027-2032 ($ millions)
Figure 52. APAC Targeted Radiotherapy Drug Market Size 2027-2032 ($ millions)
Figure 53. Europe Targeted Radiotherapy Drug Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa Targeted Radiotherapy Drug Market Size 2027-2032 ($ millions)
Figure 55. United States Targeted Radiotherapy Drug Market Size 2027-2032 ($ millions)
Figure 56. Canada Targeted Radiotherapy Drug Market Size 2027-2032 ($ millions)
Figure 57. Mexico Targeted Radiotherapy Drug Market Size 2027-2032 ($ millions)
Figure 58. Brazil Targeted Radiotherapy Drug Market Size 2027-2032 ($ millions)
Figure 59. China Targeted Radiotherapy Drug Market Size 2027-2032 ($ millions)
Figure 60. Japan Targeted Radiotherapy Drug Market Size 2027-2032 ($ millions)
Figure 61. Korea Targeted Radiotherapy Drug Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia Targeted Radiotherapy Drug Market Size 2027-2032 ($ millions)
Figure 63. India Targeted Radiotherapy Drug Market Size 2027-2032 ($ millions)
Figure 64. Australia Targeted Radiotherapy Drug Market Size 2027-2032 ($ millions)
Figure 65. Germany Targeted Radiotherapy Drug Market Size 2027-2032 ($ millions)
Figure 66. France Targeted Radiotherapy Drug Market Size 2027-2032 ($ millions)
Figure 67. UK Targeted Radiotherapy Drug Market Size 2027-2032 ($ millions)
Figure 68. Italy Targeted Radiotherapy Drug Market Size 2027-2032 ($ millions)
Figure 69. Russia Targeted Radiotherapy Drug Market Size 2027-2032 ($ millions)
Figure 70. Egypt Targeted Radiotherapy Drug Market Size 2027-2032 ($ millions)
Figure 71. South Africa Targeted Radiotherapy Drug Market Size 2027-2032 ($ millions)
Figure 72. Israel Targeted Radiotherapy Drug Market Size 2027-2032 ($ millions)
Figure 73. Turkey Targeted Radiotherapy Drug Market Size 2027-2032 ($ millions)
Figure 74. Global Targeted Radiotherapy Drug Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global Targeted Radiotherapy Drug Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries Targeted Radiotherapy Drug Market Size 2027-2032 ($ millions)